On September 10, the 8th round of negotiations for the Trans-Pacific Partnership Trade Agreement (TPPA) – a controversial pact between the U.S. and eight countries in the Asia-Pacific region – will be taking place in Chicago. The meeting will include trade representatives from the U.S., Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore and Vietnam – and other stakeholders such as corporations with global interests.
The negotiations will consider inclusion of pre-grant opposition procedures, a process which allows interested parties to submit information to the patent examiner before deciding whether or not to approve a drug firm’s application for a patent. Global health advocates argue that the process facilitates increased access to affordable medicines…
In a new article published today in the journal Nature, a team of researchers reported the isolation of 17 novel antibodies capable of deactivating a broad spectrum of HIV variants – which could be huge in the development of an HIV vaccine.
The team of researchers hailed from the International AIDS Vaccine Initiative (IAVI), the Scripps Research Institute, Theraclone Sciences and Monogram Biosciences Inc.
Science Speaks interviewed one of the paper’s co-authors, Wayne C. Koff, PhD, on this exciting new science to get a better grasp on the thinking behind broadly neutralizing antibodies (bNAbs) and the AIDS vaccine development process.
Creative and Novel Ideas in HIV Research (CNIHR), in collaboration with the International AIDS Society (IAS), The National Institutes of Health (NIH) and NIH-funded Centers for AIDS Research (CFAR), has announced a research grant program for early career investigators with no prior experience in HIV research. The program is sponsored by the National Centers for […]
While the Society for International Development 2011 World Congress focused on the general topic of development, a breakout session Friday on vertical and integrated approaches to global health, with panelists including Robert Clay and Ann Gavaghan, addressed the question of how best to achieve sustainable results, citing specific examples from the field.
The U.S. Department of Defense might not incite thoughts of contributions to global health, but a briefing Thursday on Capitol Hill shed new light on that thinking.
“The Walter Reed Army Institute of Research (WRAIR) is one of the largest developers of vaccines in the non-private sector,” said Peter Hotez, MD, PhD…